bioRxivBiophysics
Online biophysical predictions for SARS-CoV-2 proteins
L. Kagami, J. Roca-Martinez, J. Gavalda-Garcia, P. Ramasamy, K. A. Feenstra, W. F. Vranken
Abstract
The SARS-CoV-2 virus, the causative agent of COVID-19, consists of an assembly of proteins that determine its infectious and immunological behavior, as well as its response to therapeutics. Major structural biology efforts on these proteins have already provided essential insights into the mode of action of the virus, as well as avenues for structure-based drug design. However, not all of the SARS-CoV-2 proteins, or regions thereof, have a well-defined three-dimensional structure, and as such might exhibit ambiguous, dynamic behaviour that is not evident from static structure representations, nor from molecular dynamics simulations using these structures. We here present a website (http://sars2.bio2byte.be/) that provides protein sequence-based predictions of the backbone and side-chain dynamics and conformational propensities of these proteins, as well as derived early folding, disorder, {beta}-sheet aggregation and protein-protein interaction propensities. These predictions attempt to capture the emergent properties of the proteins, so the inherent biophysical propensities encoded in the sequence, rather than context-dependent behaviour such as the final folded state. In addition, we provide an indication of the biophysical variation that is observed in homologous proteins, which give an indication of the limits of the functionally relevant biophysical behaviour of these proteins. With this website, we therefore hope to provide researchers with further clues on the behaviour of SARS-CoV-2 proteins.
- organism: virus
- assay: protein sequence
- research focus: protein structure prediction
- approach: deep learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional and druggability analysis of the SARS-CoV-2 proteome
Claudio N. Cavasotto, Maximiliano Sánchez‐Lamas, Julián Maggini·European Journal of PharmacologyPeer-reviewed·Nov 1, 2020
- Characterization and Structural Prediction of ORF10, ORF7b, ORF7a, ORF6, Membrane Glycoprotein, and Envelope Protein in SARS-CoV-2 Bangladeshi Variant through Bioinformatics Approach
Pinky Debnath, Umama Khan, Md. Salauddin Khan·bioRxiv·Oct 1, 2021
- Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Proteins by Machine Learning and Physics-Based Refinement
- In silico Proteome analysis of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Chittaranjan Baruah, Papari Devi, Dhirendra Kumar Sharma·bioRxiv·May 23, 2020
- When Darkness Becomes a Ray of Light in the Dark Times: Understanding the COVID-19 via the Comparative Analysis of the Dark Proteomes of SARS-CoV-2, Human SARS and Bat SARS-Like Coronaviruses
Rajanish Giri, Taniya Bhardwaj, … Vladimir Nikolaevich Uversky·Cellular and Molecular Life SciencesPeer-reviewed·Jul 25, 2020
- A BioID-derived proximity interactome for SARS-CoV-2 proteins
Danielle G. May, Laura Martin‐Sancho, … Kyle J. Roux·VirusesPeer-reviewed·Mar 15, 2022